T Allen1, V W Willard2, L M Anderson1, K K Hardy3, M J Bonner4. 1. Duke University, Psychology and Neuroscience, Durham, NC, United States. 2. St. Jude Children's Research Hospital, Psychology, Memphis, TN, United States. 3. Children's National Medical Center, Center for Neuroscience and Behavioral Medicine, Washington, DC, United States. 4. Duke University Medical Center, Psychiatry, Durham, NC, United States.
Abstract
BACKGROUND: This study examined social functioning and facial expression recognition (FER) in children with neurofibromatosis type 1 (NF1) compared to typically developing peers. Specifically, the current research aimed to identify hypothesised relationships between neurocognitive ability, FER and social functioning. METHOD: Children, ages 8 to 16, with NF1 (n = 23) and typically developing peers (n = 23) were recruited during regularly scheduled clinic visits and through advertisements on an institutional clinical trials website, respectively. Participants completed a measure of FER, an abbreviated intelligence test and questionnaires regarding their quality of life and behavioural functioning. Parents were also asked to complete questionnaires regarding the social-emotional and cognitive functioning of their child. RESULTS: As expected, there were significant differences between children with NF1 and typically developing peers across domains of social functioning and FER. Within the sample of children with NF1, there were no significant associations observed between cognitive measures, social functioning and facial recognition skills. CONCLUSION: Children with NF1 exhibited high rates of social impairment and weak FER skills compared to controls. The absence of associations between FER with cognitive and social variables, however, suggests something unique about this skill in children with NF1. Theoretical comparisons are made to children with autism spectrum disorders, as this condition may serve as a potentially useful model in better understanding FER in children with NF1.
BACKGROUND: This study examined social functioning and facial expression recognition (FER) in children with neurofibromatosis type 1 (NF1) compared to typically developing peers. Specifically, the current research aimed to identify hypothesised relationships between neurocognitive ability, FER and social functioning. METHOD:Children, ages 8 to 16, with NF1 (n = 23) and typically developing peers (n = 23) were recruited during regularly scheduled clinic visits and through advertisements on an institutional clinical trials website, respectively. Participants completed a measure of FER, an abbreviated intelligence test and questionnaires regarding their quality of life and behavioural functioning. Parents were also asked to complete questionnaires regarding the social-emotional and cognitive functioning of their child. RESULTS: As expected, there were significant differences between children with NF1 and typically developing peers across domains of social functioning and FER. Within the sample of children with NF1, there were no significant associations observed between cognitive measures, social functioning and facial recognition skills. CONCLUSION:Children with NF1 exhibited high rates of social impairment and weak FER skills compared to controls. The absence of associations between FER with cognitive and social variables, however, suggests something unique about this skill in children with NF1. Theoretical comparisons are made to children with autism spectrum disorders, as this condition may serve as a potentially useful model in better understanding FER in children with NF1.
Authors: Anita K Chisholm; Vicki A Anderson; Natalie A Pride; Stephanie Malarbi; Kathryn N North; Jonathan M Payne Journal: Neuropsychol Rev Date: 2018-08-11 Impact factor: 7.444
Authors: Staci Martin; Kari L Struemph; Alyssa Poblete; Mary Anne Toledo-Tamula; Robin Lockridge; Marie Claire Roderick; Pamela Wolters Journal: J Community Genet Date: 2018-03-02
Authors: Danielle M Glad; Christina L Casnar; Brianna D Yund; Kristin Lee; Bonita P Klein-Tasman Journal: J Dev Behav Pediatr Date: 2021 Oct-Nov 01 Impact factor: 2.225
Authors: Andrew J D Crow; Jennica M Janssen; Carolina Marshall; Anne Moffit; Laura Brennan; Christian G Kohler; David R Roalf; Paul J Moberg Journal: Am J Med Genet A Date: 2022-05-12 Impact factor: 2.578
Authors: Elizabeth I Pierpont; Rebekah L Hudock; Allison M Foy; Margaret Semrud-Clikeman; Mary Ella Pierpont; Susan A Berry; Ryan Shanley; Nathan Rubin; Katherine Sommer; Christopher L Moertel Journal: J Neurodev Disord Date: 2018-06-18 Impact factor: 4.025
Authors: Kristina M Haebich; Natalie A Pride; Karin S Walsh; Anita Chisholm; Melissa Rouel; Alice Maier; Vicki Anderson; Belinda Barton; Tim Silk; Mayuresh Korgaonkar; Marc Seal; Francesca Lami; Jennifer Lorenzo; Katrina Williams; Gabriel Dabscheck; Caroline D Rae; Michael Kean; Kathryn N North; Jonathan M Payne Journal: BMJ Open Date: 2019-09-26 Impact factor: 2.692
Authors: Jennifer A Janusz; Bonita P Klein-Tasman; Jonathan M Payne; Pamela L Wolters; Heather L Thompson; Staci Martin; Peter de Blank; Nicole Ullrich; Allison Del Castillo; Maureen Hussey; Kristina K Hardy; Kristina Haebich; Tena Rosser; Mary Anne Toledo-Tamula; Karin S Walsh Journal: Neurology Date: 2021-07-06 Impact factor: 11.800